BlossomHill Therapeutics, Inc. (BLSM) Form 10-Q Quarterly Reports
BlossomHill Therapeutics, Inc. (BLSM) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BLSM
CIK: 1839970
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte & Touche LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerBruce Rucks
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-09-18 | 2026-06-30 | 10-Q | 0001193125-26-395043 | View SEC Doc Filr Page |
| 8-K | 2026-09-18 | 2026-09-18 | 8-K | 0001193125-26-395031 | View SEC Doc Filr Page |
| 8-K | 2026-09-15 | 2026-09-15 | 8-K | 0001193125-26-391328 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-08-18 | — | SCHEDULE 13D Filing | 0000947871-26-000813 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-17 | — | SCHEDULE 13G Filing | 0001213900-26-090726 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001193125-26-352634 | View SEC Doc Filr Page |
| SCHEDULE 13D | 2026-08-13 | — | SCHEDULE 13D Filing | 0000929638-26-003026 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-10 | 4 Filing | 0000947871-26-000785 | View SEC Doc Filr Page |
| 4 | 2026-08-12 | 2026-08-10 | 4 Filing | 0000947871-26-000784 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-10 | 4 Filing | 0001478916-26-000015 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-06 | 4 Filing | 0001282930-26-000008 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-06 | 4 Filing | 0001231919-26-000852 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-06 | 4 Filing | 0001840599-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-06 | 4 Filing | 0001678152-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-06 | 4 Filing | 0002143905-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-06 | 4 Filing | 0002144320-26-000003 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-06 | 4 Filing | 0001772233-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-06 | 4 Filing | 0001772259-26-000005 | View SEC Doc Filr Page |
| S-8 | 2026-08-10 | — | S-8 | 0001193125-26-342572 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | 8-K | 0001193125-26-342316 | View SEC Doc Filr Page |
| 424B4 | 2026-08-07 | — | 424B4 | 0001193125-26-340215 | View SEC Doc Filr Page |
| EFFECT | 2026-08-06 | — | EFFECT Filing | 9999999995-26-002565 | View SEC Doc Filr Page |
| 3 | 2026-08-06 | 2026-08-06 | 3 Filing | 0000947871-26-000751 | View SEC Doc Filr Page |
| 3 | 2026-08-06 | 2026-08-06 | 3 Filing | 0001478916-26-000014 | View SEC Doc Filr Page |
| 3 | 2026-08-06 | 2026-08-06 | 3 Filing | 0001575202-26-000013 | View SEC Doc Filr Page |